Browse studies

Find your next paid study

27,365 recruiting studies available now

Effects of Blood Pressure on Cognition and Cerebral Blood Flow in Parkinson Disease

Parkinson's disease (PD) is the second most common neurodegenerative disorder worldwide. Besides causing symptoms that impair movement, PD also causes non-moto…

Parkinson DiseaseOrthostatic HypotensionDysautonomia

Estimated

~$10 – $6,250

University of California, San DiegoNCT05400174

Phase 2

A Phase 2, Double Blind, Randomized, Placebo-controlled Crossover Trial to Evaluate the Efficacy and Safety of Atomoxetine in Adults With Melanocortin Obesity Syndrome

This is a phase 2 randomized placebo-controlled crossover trial to determine the safety and efficacy of atomoxetine for treating obesity caused by loss-of-func…

Melanocortin Obesity SyndromeMCOS

Estimated

~$10 – $6,250

Icahn School of Medicine at Mount SinaiNCT06899178

Phase 3

A Phase III Trial Of The Impact Of Sentinel Lymph Node Mapping On Patient Reported Lower Extremity Limb Dysfunction In Endometrial Cancer

This phase III trial compares the effect of sentinel lymph node mapping to standard lymph node dissection in reducing the risk of swelling in the legs (lymphed…

Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8

Estimated

~$10 – $7,500

NRG OncologyNCT05646316

Observational

Generalized and Domain-Specific Episodic Thinking for Smoking Cessation: An 8-Week Pilot and Feasibility Trial

Cigarette smoking remains common, particularly in rural areas, despite ample evidence that smoking causes cancer and respiratory disease. Successful smoking ce…

Cigarette Smoking Behavior

Estimated

~$10 – $6,250

Virginia Polytechnic Institute and State UniversityNCT07158749

Phase 1

MATCHPOINT - Medulloblastoma Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade

This is a pilot study in a small number of children and young adults with suspected recurrent/progressive medulloblastoma (MB) looking at the feasibility and s…

Recurrent Group 3 MedulloblastomaRecurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma

Estimated

~$10 – $6,250

University of FloridaNCT06514898

Phase 2

A Phase II Study With a Safety Run-In of the Addition of N-803, a Novel IL-15 Super-Agonist, to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma

The study participant is being asked to take part in this research study because the participant has been diagnosed with neuroblastoma that did not fully respo…

Neuroblastoma Recurrent

Estimated

~$10 – $6,250

St. Jude Children's Research HospitalNCT07085338

Observational

Improving Patient-Centered Care in Pediatric Acute Kidney Injury (Change Peds AKI)

The purpose of this study is to improve patient-centered care for acute kidney injury (AKI) in order to decrease the adverse health outcomes associated with th…

Acute Kidney Injury

Estimated

~$10 – $6,250

Duke UniversityNCT04403633

Phase 1

Dosimetry and Bio-distribution of 203Pb-RMX-VH-PIB in Newly Diagnosed or Recurrent Patients With Solid Tumors: A Phase I Exploratory Study

The goal of this Phase I clinical trial is to evaluate how the imaging drug 203Pb- RMX-VH-PIB distributes in the body and how much radiation different organs r…

Glioblastoma Multiforme (GBM)Pancreatic Ductal Adenocarcinoma (PDAC)

Estimated

~$10 – $8,750

Radiomedix, Inc.NCT07733674

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

The aim is to compare the rate of hypertensive subjects with ICH who reach SBP target with stability within 60 minutes of enrollment, among patients treated wi…

Intracerebral HemorrhageStrokeHypertension

Estimated

~$10 – $1,125

Zeenat Qureshi Stroke InstituteNCT06402968

Phase 3

A Phase 3b Multicenter Open-label Trial of the Safety, Tolerability, and Efficacy of Tolvaptan in Infants and Children 28 Days to Less Than 18 Years of Age With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

To evaluate the pharmacodynamics and safety of tolvaptan in pediatric subjects with ARPKD

Autosomal Recessive Polycystic Kidney (ARPKD)

Estimated

~$10 – $8,750

Otsuka Pharmaceutical Development & Commercialization, Inc.NCT04782258

Phase 3

Prospective Randomized Evaluation of Analgesia for Cardiac Elective Surgery in Children (PRECISE Cardiac Trial)

The purpose of this study is to look at a standardized methadone-based enhanced recovery after surgery protocol following pediatric cardiac surgery. This study…

Pediatric Cardiac Surgery

Estimated

~$10 – $7,500

Senthil SadhasivamNCT06626035

Observational

Randomized Controlled Trial of Moderate Dose Hydrogen Water as a Treatment for ME/CFS

This is a 16-week controlled treatment trial of an over-the -counter supplement, hydrogen water, for individuals with ME/CFS patients. An active treatment cond…

Chronic Fatigue Syndrome (CFS)

Estimated

~$10 – $7,500

Fred FriedbergNCT07753122